CIK 0001583771 · Non-accelerated filer<br>Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462783806
- Phone
- 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Stetz Gary S. II Director | Purchase · Warrants | +500,000 | 500,000 | ||
| 2026-08-03 | Stetz Gary S. Interim CEO | Purchase | +2,000,000 | $0.05 | $100K | 3,250,000 |
| 2026-08-03 | Stetz Gary S. Interim CEO | Purchase · Warrants | +2,000,000 | 2,000,000 | ||
| 2026-08-03 | Purcell Michael J. Director | Purchase | +2,000,000 | $0.05 | $100K | 3,250,000 |
| 2026-08-03 | Purcell Michael J. Director | Purchase · Warrants | +2,000,000 | 2,000,000 | ||
| 2026-08-03 | Appajosyula Sireesh Chief Operating Officer | Purchase | +2,000,000 | $0.05 | $100K | 3,250,000 |
| 2026-08-03 | Appajosyula Sireesh Chief Operating Officer | Purchase · Warrants | +2,000,000 | 2,000,000 | ||
| 2026-08-03 | LoPriore Vincent S Executive Chairman | Purchase | +8,000,000 | $0.05 | $400K | 14,250,000 |
| 2026-08-03 | LoPriore Vincent S Executive Chairman | Purchase | +2,000,000 | $0.05 | $100K | 16,250,000 |
| 2026-08-03 | LoPriore Vincent S Executive Chairman | Purchase · Warrants | +8,000,000 | 8,000,000 | ||
| 2026-08-03 | LoPriore Vincent S Executive Chairman | Purchase · Warrants | +2,000,000 | 10,000,000 | ||
| 2026-04-21 | Purcell Michael J. Director | Purchase | +1,250,000 | $0.04 | $50K | 1,250,000 |
| 2026-04-21 | LoPriore Vincent S Executive Chairman | Purchase | +5,000,000 | $0.04 | $200K | 5,000,000 |
| 2026-04-21 | LoPriore Vincent S Executive Chairman | Purchase | +1,250,000 | $0.04 | $50K | 6,250,000 |
| 2026-04-21 | Appajosyula Sireesh Director | Purchase | +1,250,000 | $0.04 | $50K | 1,250,000 |
| 2026-04-21 | Stetz Gary S. Interim CEO | Purchase | +1,250,000 | $0.04 | $50K | 1,250,000 |
| 2024-03-06 | Purcell Michael J. Director | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2024-02-19 | Block Timothy M. Director | Grant or award · Stock Options | +85,000 | 99,562 | ||
| 2024-02-19 | Lbiati Kaouthar Director | Grant or award · Stock Options | +85,000 | 88,000 | ||
| 2024-02-19 | BRANCACCIO JOHN P Chairman | Grant or award · Stock Options | +85,000 | 99,563 |
Page 2 of 6 · 119 trades